-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Oj/LXbJaaRVkoIdaF0y2oYvVHU2GtCIS95hkVPO1N/vqRd5jfZ/05QXVY5t9666t xd9/Xp5If4xVHTzmQLjNXQ== 0001209191-08-011650.txt : 20080220 0001209191-08-011650.hdr.sgml : 20080220 20080220133336 ACCESSION NUMBER: 0001209191-08-011650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080219 FILED AS OF DATE: 20080220 DATE AS OF CHANGE: 20080220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHNEIER CRAIG ERIC CENTRAL INDEX KEY: 0001226289 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 08629136 BUSINESS ADDRESS: BUSINESS PHONE: 6176792000 MAIL ADDRESS: STREET 1: BIOGEN INC LEGAL DEPARTMENT STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6176792000 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-02-19 0 0000875045 BIOGEN IDEC INC. BIIB 0001226289 SCHNEIER CRAIG ERIC 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 0 1 0 0 EVP, HR, Public Affairs & Comm Common Stock 2008-02-19 4 S 0 400 62.74 D 29529.85 D Common Stock 2008-02-19 4 S 0 200 62.79 D 29329.85 D Common Stock 2008-02-19 4 S 0 100 62.98 D 29229.85 D Common Stock 2008-02-19 4 S 0 400 63.11 D 28829.85 D Common Stock 2008-02-19 4 S 0 200 63.18 D 28629.85 D Common Stock 2008-02-19 4 S 0 200 63.26 D 28429.85 D Common Stock 2008-02-19 4 S 0 400 63.28 D 28029.85 D Common Stock 2008-02-19 4 S 0 144 63.30 D 27885.85 D Common Stock 2008-02-19 4 S 0 200 63.33 D 27685.85 D Common Stock 2008-02-19 4 S 0 300 63.39 D 27385.85 D Common Stock 2008-02-19 4 S 0 400 63.41 D 26985.85 D Common Stock 2008-02-19 4 S 0 400 63.43 D 26585.85 D Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Scott Lively, Attorney in Fact for Craig E. Schneier 2008-02-20 -----END PRIVACY-ENHANCED MESSAGE-----